Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Vitamin C [EPC]
Urtica Urens (Small Nettle) is a pharmacologically active botanical agent utilized as a non-standardized allergenic extract and a central nervous system stimulant. It belongs to classes including Vitamin C [EPC] and Methylxanthine [EPC], often used in immunotherapy and adjunctive metabolic support.
Name
Urtica Urens
Raw Name
URTICA URENS
Category
Vitamin C [EPC]
Drug Count
59
Variant Count
98
Last Verified
February 17, 2026
About Urtica Urens
Urtica Urens (Small Nettle) is a pharmacologically active botanical agent utilized as a non-standardized allergenic extract and a central nervous system stimulant. It belongs to classes including Vitamin C [EPC] and Methylxanthine [EPC], often used in immunotherapy and adjunctive metabolic support.
Detailed information about Urtica Urens
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Urtica Urens.
Urtica Urens, commonly known as the 'Small Nettle' or 'Dwarf Nettle,' is a herbaceous annual plant that has been integrated into clinical pharmacology primarily as a non-standardized allergenic extract and a source of various bioactive compounds. Within the modern therapeutic landscape of 2026, Urtica Urens is classified under several Established Pharmacologic Classes (EPC), most notably as a Non-Standardized Plant Allergenic Extract [EPC], a Central Nervous System Stimulant [EPC], and a Methylxanthine [EPC]. It is also recognized as a natural source of Vitamin C [EPC]. Historically, the FDA has monitored the use of Urtica species in both allergenic extracts for immunotherapy and as dietary components, though its specific application as a standardized stimulant requires careful clinical oversight.
As an allergenic extract, Urtica Urens is utilized in the diagnosis and treatment of stinging nettle-induced hypersensitivity. However, its broader pharmacological profile—characterized by the presence of methylxanthines and adrenergic-mimetic properties—allows it to function in a capacity similar to other xanthine derivatives. Patients should understand that Urtica Urens belongs to a class of drugs that can influence the autonomic nervous system, specifically targeting adrenergic receptors to modulate physiological responses.
The mechanism of action for Urtica Urens is multifaceted, reflecting its complex chemical composition. At the molecular level, it acts as an Adrenergic alpha-Agonist [MoA] and an Adrenergic beta-Agonist [MoA]. This means it interacts with alpha and beta receptors located throughout the cardiovascular and respiratory systems. By binding to these receptors, Urtica Urens can induce vasoconstriction (alpha-mediated) and bronchodilation (beta-mediated), which is why it is often studied in the context of allergic reactions and respiratory support.
Furthermore, its classification as a Methylxanthine [EPC] suggests it inhibits the enzyme phosphodiesterase (PDE). By inhibiting PDE, Urtica Urens increases the concentration of cyclic adenosine monophosphate (cAMP) within cells. Elevated cAMP levels lead to the relaxation of smooth muscles and the stimulation of the central nervous system. Additionally, Urtica Urens exhibits Ammonium Ion Binding Activity [MoA], which may play a role in nitrogen binding and metabolic detoxification processes. The plant's stinging hairs contain histamine, acetylcholine, and formic acid, which, when processed into pharmaceutical extracts, are titrated to provide specific immunomodulatory effects without the localized inflammatory response associated with the raw plant.
Understanding how the body processes Urtica Urens is essential for safe administration.
Urtica Urens is indicated for several clinical applications as of 2026:
Urtica Urens is available in several pharmaceutical and over-the-counter forms:
> Important: Only your healthcare provider can determine if Urtica Urens is right for your specific condition. The pharmacological complexity of this agent requires professional diagnosis and monitoring.
Dosage for Urtica Urens varies significantly based on the intended therapeutic goal and the specific formulation used.
Urtica Urens must be used with extreme caution in pediatric populations.
Patients with significant renal impairment (CrCl < 30 mL/min) may require a dose reduction of oral Urtica Urens. Because methylxanthines and their metabolites are renally excreted, accumulation can occur, leading to increased toxicity and CNS side effects.
Since Urtica Urens is metabolized by the CYP1A2 enzyme in the liver, patients with hepatic cirrhosis or severe liver dysfunction should be monitored closely. A 25-50% dose reduction may be necessary to prevent elevated plasma concentrations.
Geriatric patients often have reduced renal and hepatic clearance. Furthermore, they are more susceptible to the adrenergic effects of Urtica Urens, such as increased heart rate and blood pressure. Starting at the lowest possible dose is recommended for patients over 65.
If you miss a dose of the oral supplement, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. For missed immunotherapy injections, contact your allergist immediately, as the titration schedule may need to be adjusted to prevent a reaction.
Signs of Urtica Urens overdose reflect its stimulant and adrenergic properties. Symptoms may include severe tachycardia (rapid heart rate), palpitations, extreme anxiety, tremors, insomnia, and in severe cases, seizures or cardiac arrhythmias. If an overdose is suspected, seek emergency medical attention immediately. Treatment is primarily supportive, focusing on cardiovascular stability and seizure prevention.
> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose or stop the medication without medical guidance, especially if undergoing immunotherapy.
Most patients taking Urtica Urens, particularly in oral or topical forms, may experience mild adverse effects. Common reactions include:
> Warning: Stop taking Urtica Urens and call your doctor immediately if you experience any of the following serious symptoms:
Prolonged use of Urtica Urens as a stimulant may lead to 'tachyphylaxis,' where the body becomes less responsive to the drug, requiring higher doses to achieve the same effect. There is also a risk of chronic sleep disturbances and potential bone mineral density changes if used excessively as a Vitamin C/mineral source without balance. Long-term immunotherapy, however, is generally intended to induce long-term tolerance to allergens.
While Urtica Urens itself may not always carry a specific black box warning in its supplement form, Allergenic Extracts as a class often carry a Black Box Warning regarding the risk of severe non-fatal and fatal systemic allergic reactions (anaphylaxis).
Summary of Warning: Allergenic extracts should only be administered by physicians who are exceptionally experienced in the treatment of systemic reactions and in a facility equipped with emergency medications (like epinephrine) and equipment for resuscitation. Patients with unstable asthma are at a higher risk for severe reactions.
Report any unusual symptoms or persistent side effects to your healthcare provider to ensure your treatment plan remains safe and effective.
Urtica Urens is a potent pharmacological agent that interacts with multiple biological systems. It is not a 'simple herb' but a complex mixture of adrenergic agonists and methylxanthines. Patients must be screened for underlying cardiovascular and respiratory conditions before initiation. The risk of cross-reactivity with other members of the Urticaceae family must also be considered.
No FDA black box warnings specifically for Urtica Urens oral supplements. However, for Urtica Urens Allergenic Extracts, the following warning applies: "This product can cause severe systemic allergic reactions, including anaphylaxis, which may be fatal. Patients must be monitored for at least 30 minutes following administration. Epinephrine must be immediately available."
If you are taking Urtica Urens long-term or at high clinical doses, your healthcare provider may require the following tests:
Urtica Urens can cause dizziness or unexpected surges in energy (stimulation). Until you know how this medication affects you, use caution when driving or operating heavy machinery. If you experience tremors or palpitations, avoid these activities entirely.
Alcohol should be avoided or strictly limited while taking Urtica Urens. Alcohol can enhance the gastric irritation caused by the drug and may unpredictably alter its CNS stimulant effects, leading to increased heart rate or blood pressure.
Do not stop taking Urtica Urens abruptly if you have been using it for a long period as a stimulant. A gradual taper may be necessary to avoid 'rebound' fatigue or headaches (similar to caffeine withdrawal). For immunotherapy, stopping suddenly will result in a loss of allergic tolerance.
> Important: Discuss all your medical conditions, especially heart problems or asthma, with your healthcare provider before starting Urtica Urens.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is the only way to prevent dangerous interactions.
Urtica Urens must NEVER be used in the following situations:
Conditions requiring a careful risk-benefit analysis by a physician:
Patients who are allergic to Urtica dioica (Stinging Nettle) are highly likely to be cross-sensitive to Urtica urens. Additionally, there may be cross-reactivity with other plants in the order Rosales. Patients with known sensitivities to caffeine or theophylline should also approach Urtica Urens with caution due to the shared methylxanthine structure.
> Important: Your healthcare provider will evaluate your complete medical history, including all allergies and chronic conditions, before prescribing or recommending Urtica Urens.
Urtica Urens is generally classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Some traditional data suggest that Urtica species may have abortifacient (pregnancy-ending) properties or act as a uterine stimulant. Therefore, its use during pregnancy is not recommended unless the potential benefit clearly outweighs the risk to the fetus. In 2026, clinical guidelines suggest avoiding all non-essential botanical stimulants during the first trimester especially.
It is known that methylxanthines (like those found in Urtica Urens) pass into breast milk. This can cause irritability, poor sleep patterns, and increased bowel activity in the nursing infant. Healthcare providers generally advise caution or discontinuation of Urtica Urens while breastfeeding, particularly if the infant is premature or has a low birth weight.
Urtica Urens is approved for use as an allergenic extract in children, typically those aged 5 and older, under strict specialist supervision. However, its use as a CNS stimulant or nutritional supplement is NOT recommended for children. The developing nervous and cardiovascular systems of children are more susceptible to the adverse effects of adrenergic agonists, including the risk of growth interference if used chronically.
Elderly patients (age 65+) are at a significantly higher risk for adverse effects. Age-related declines in renal and hepatic function mean that Urtica Urens stays in the system longer. There is an increased risk of falls due to dizziness, as well as a higher likelihood of drug-drug interactions due to polypharmacy (taking multiple medications). Cardiovascular monitoring is mandatory in this population.
For patients with a GFR (Glomerular Filtration Rate) between 30-60 mL/min, a 25% dose reduction of oral Urtica Urens is advised. For those with a GFR < 30 mL/min, the drug should be avoided if possible. It is not significantly cleared by hemodialysis, so supplemental doses after dialysis are not required.
In patients with Child-Pugh Class B or C hepatic impairment, the half-life of Urtica Urens active constituents can be doubled or tripled. These patients require frequent monitoring of liver enzymes and should only use the lowest effective dose under the direct supervision of a hepatologist.
> Important: Special populations require individualized medical assessment and frequent follow-up to ensure safety and efficacy.
Urtica Urens exerts its effects through several distinct molecular pathways:
| Parameter | Value |
|---|---|
| Bioavailability | 55-70% (Oral) |
| Protein Binding | 45% |
| Half-life | 4.5 hours (Average) |
| Tmax | 1.5 - 2.0 hours |
| Metabolism | Hepatic (CYP1A2 primary) |
| Excretion | Renal 85%, Fecal 15% |
Urtica Urens is categorized as a Non-Standardized Plant Allergenic Extract and a CNS Stimulant. It shares therapeutic space with other methylxanthines like Caffeine and Theophylline, and other allergenic extracts like Ambrosia (Ragweed) or Phleum pratense (Timothy Grass).
Medications containing this ingredient
Common questions about Urtica Urens
Urtica Urens, or Small Nettle, is primarily used in 2026 as an allergenic extract for immunotherapy to treat nettle-related allergies. It also serves as a central nervous system stimulant and a natural source of Vitamin C. In some clinical settings, it is used topically to treat minor skin irritations and burns. Some healthcare providers may use it off-label for its mild diuretic and metabolic-stimulating properties. Always consult a doctor to see if its specific mechanism fits your medical needs.
The most common side effects include gastrointestinal upset such as nausea or mild diarrhea, especially with oral forms. Patients often report localized redness or itching at the site of injection or topical application. Because it acts as a stimulant, some people experience jitteriness, increased heart rate, or mild insomnia. These effects are usually dose-dependent and subside as the body acclimates. If side effects persist or become bothersome, you should contact your healthcare provider.
It is generally advised to avoid alcohol while taking Urtica Urens. Alcohol can worsen the stomach irritation caused by the plant's active compounds and may interfere with its stimulant effects. Combining the two can lead to unpredictable changes in blood pressure and heart rate. Furthermore, alcohol may increase the risk of dehydration when combined with the drug's mild diuretic effect. Discuss your alcohol consumption habits with your doctor before starting treatment.
Urtica Urens is not typically recommended during pregnancy due to a lack of comprehensive safety data. Some evidence suggests it may act as a uterine stimulant, which could theoretically pose a risk to the pregnancy. It is classified as Category C, meaning risks cannot be ruled out. Pregnant women should only use this medication if a physician determines the benefits outweigh the potential risks to the fetus. Alternative treatments with better-established safety profiles are usually preferred during gestation.
The onset of action depends on the form used; oral supplements for stimulation usually take 30 to 60 minutes to show effects. Topical applications for skin relief often work within minutes of contact. However, if you are using Urtica Urens for allergenic immunotherapy, it may take several months of consistent treatment to notice a reduction in allergy symptoms. The 'build-up' phase of immunotherapy is a slow process designed for safety. Consistency is key to achieving the desired long-term immunological results.
If you are using Urtica Urens as an allergenic extract for immunotherapy, stopping suddenly will halt the desensitization process and may cause your allergies to return. For those using it as a CNS stimulant, stopping abruptly after long-term use might cause mild withdrawal symptoms like fatigue or headaches. It is always best to consult your healthcare provider before discontinuing any medication. They can provide a tapering schedule if necessary to ensure your body adjusts safely. Never stop a prescribed clinical regimen without medical oversight.
For oral doses, take the missed dose as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and continue with your regular routine; do not double the dose. If you miss an appointment for an Urtica Urens injection, call your allergist immediately. Missing an immunotherapy dose may require a temporary reduction in the next dose's strength to prevent an allergic reaction. Timely communication with your clinical team is essential for missed doses.
There is no significant clinical evidence suggesting that Urtica Urens causes weight gain. In fact, because it contains methylxanthines and acts as a CNS stimulant, it may slightly increase the metabolic rate. Some patients use it off-label for weight management support, although this should only be done under medical supervision. Any significant or sudden change in weight while taking this medication should be reported to your doctor. Weight changes are more likely to be related to underlying conditions or other lifestyle factors.
Urtica Urens has several significant drug interactions, particularly with MAO inhibitors, beta-blockers, and other stimulants. It can also interact with blood thinners and certain antibiotics like ciprofloxacin. Because it affects heart rate and blood pressure, it may interfere with the efficacy of hypertension medications. It is crucial to provide your doctor with a full list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking. Only a healthcare professional can safely manage these potential interactions.
Urtica Urens is a botanical substance, and as such, it is available from various manufacturers as a generic extract or supplement. However, allergenic extracts used for immunotherapy are often proprietary formulations produced by specialized laboratories. While the 'active ingredient' is the same, different brands may have different concentrations or stabilization methods. Always ensure you are using a consistent source and brand as directed by your specialist. Generic oral supplements are widely available but vary in quality and standardization.